IL126681A0 - Treatment of trauma-related conditions - Google Patents

Treatment of trauma-related conditions

Info

Publication number: IL126681A0
Authority: IL; Israel
Prior art keywords: trauma; treatment; related conditions; conditions
Prior art date: 1998-10-21

Application number

IL12668198A

Original Assignee

Opperbas Holding Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-21

Filing date

1998-10-21

Publication date

1999-08-17

1998-10-21 Application filed by Opperbas Holding Bv filed Critical Opperbas Holding Bv

1998-10-21 Priority to IL12668198A priority Critical patent/IL126681A0/en

1999-08-17 Publication of IL126681A0 publication Critical patent/IL126681A0/en

1999-10-20 Priority to JP2000576888A priority patent/JP2002527492A/en

1999-10-20 Priority to AU63639/99A priority patent/AU6363999A/en

1999-10-20 Priority to EP99951067A priority patent/EP1123115A1/en

1999-10-20 Priority to PCT/IL1999/000547 priority patent/WO2000023115A1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Epidemiology (AREA)
Surgery (AREA)
Genetics & Genomics (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Gastroenterology & Hepatology (AREA)
Biotechnology (AREA)
Urology & Nephrology (AREA)
Molecular Biology (AREA)
Transplantation (AREA)
Dispersion Chemistry (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

IL12668198A 1998-10-21 1998-10-21 Treatment of trauma-related conditions IL126681A0 (en)

Priority Applications (5)

Application Number	Priority Date	Filing Date	Title
IL12668198A IL126681A0 (en)	1998-10-21	1998-10-21	Treatment of trauma-related conditions
JP2000576888A JP2002527492A (en)	1998-10-21	1999-10-20	Treatment of trauma (ie, graft rejection) with liposomes containing CTLA4Ig or DNA encoding anti-CD40L
AU63639/99A AU6363999A (en)	1998-10-21	1999-10-20	Treatment of trauma (i.e. graft rejection) with liposomes containing dna encoding for ctla4ig or for anti-cd40l
EP99951067A EP1123115A1 (en)	1998-10-21	1999-10-20	Treatment of trauma (ie graft rejection) with liposomes containing dna encoding for ctla4ig or for anti cd40l
PCT/IL1999/000547 WO2000023115A1 (en)	1998-10-21	1999-10-20	TREATMENT OF TRAUMA (I.E. GRAFT REJECTION) WITH LIPOSOMES CONTAINING DNA ENCODING FOR CTLA4Ig OR FOR ANTI-CD40L

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IL12668198A IL126681A0 (en)	1998-10-21	1998-10-21	Treatment of trauma-related conditions

Publications (1)

Publication Number	Publication Date
IL126681A0 true IL126681A0 (en)	1999-08-17

Family

ID=11072042

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL12668198A IL126681A0 (en)	1998-10-21	1998-10-21	Treatment of trauma-related conditions

Country Status (5)

Country	Link
EP (1)	EP1123115A1 (en)
JP (1)	JP2002527492A (en)
AU (1)	AU6363999A (en)
IL (1)	IL126681A0 (en)
WO (1)	WO2000023115A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6887471B1 (en)	1991-06-27	2005-05-03	Bristol-Myers Squibb Company	Method to inhibit T cell interactions with soluble B7
US7094874B2 (en)	2000-05-26	2006-08-22	Bristol-Myers Squibb Co.	Soluble CTLA4 mutant molecules
US20040022787A1 (en)	2000-07-03	2004-02-05	Robert Cohen	Methods for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID
SI1935427T1 (en)	2000-07-03	2018-05-31	Bristol-Myers Squibb Company	Uses of soluble CTLA4 mutant molecules
DE60219601T2 (en) *	2001-02-22	2007-12-27	Opperbas Holding B.V.	BY LIPOSOME-MEDIATED DNA ADMINISTRATION
MXPA03010568A (en)	2001-05-23	2005-03-07	Squibb Bristol Myers Co	Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2116269T3 (en) *	1989-03-21	1998-07-16	Vical Inc	EXPRESSION OF EXOGENOUS SEQUENCES OF POLYNUCLEOTIDES IN A VERTEBRATE.
US5770197A (en) *	1991-06-27	1998-06-23	Bristol-Myers Squibb Company	Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules
IL115199A (en) *	1995-09-07	2005-05-17	Opperbas Holding Bv	Composition comprising a polynucleic acid molecule in a liposome and method using said composition
US6750334B1 (en) *	1996-02-02	2004-06-15	Repligen Corporation	CTLA4-immunoglobulin fusion proteins having modified effector functions and uses therefor
CA2252055C (en) *	1996-04-11	2007-01-16	The University Of British Columbia	Fusogenic liposomes
AU5709798A (en) *	1997-01-10	1998-08-03	Biogen, Inc.	Treatment of lupus nephritis with anti-cd40l compounds

1998
- 1998-10-21 IL IL12668198A patent/IL126681A0/en unknown
1999
- 1999-10-20 JP JP2000576888A patent/JP2002527492A/en active Pending
- 1999-10-20 EP EP99951067A patent/EP1123115A1/en not_active Withdrawn
- 1999-10-20 AU AU63639/99A patent/AU6363999A/en not_active Abandoned
- 1999-10-20 WO PCT/IL1999/000547 patent/WO2000023115A1/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU6363999A (en)	2000-05-08
EP1123115A1 (en)	2001-08-16
WO2000023115A1 (en)	2000-04-27
JP2002527492A (en)	2002-08-27

Publication	Publication Date	Title
GB9824436D0 (en)	1999-01-06	Methods of treatment
GB9805419D0 (en)	1998-05-06	Treatment of liquids
AP9901683A0 (en)	1999-12-31	Treatment of water
IL126681A0 (en)	1999-08-17	Treatment of trauma-related conditions
IL140540A0 (en)	2002-02-10	Treatment of anxiety disorders
EP1107778A4 (en)	2003-07-02	Treatment of disease states
PL345261A1 (en)	2001-12-03	Method of treatment
GB2343629B (en)	2003-03-12	Treatment of cellulite
GB9805686D0 (en)	1998-05-13	Treatment of metals
HK1041202A1 (en)	2002-07-05	Novel method of treatment
GB2365419B (en)	2002-09-11	Treatment of effluents
IL141264A0 (en)	2002-03-10	Treatment of fecal incontinence
EP1143998A4 (en)	2002-06-26	Treatment of hypertension
GB9822681D0 (en)	1998-12-09	Method of treatment
GB9824208D0 (en)	1998-12-30	Methods of treatment
GB9822458D0 (en)	1998-12-09	Methods of treatment
GB9800707D0 (en)	1998-03-11	Methods of treatment
GB9813109D0 (en)	1998-08-19	Treatment of inflammatory skin conditions
GB9818295D0 (en)	1998-10-14	Treatment of alopecia
HUP0103568A3 (en)	2003-05-28	Treatment of depression
GB9824791D0 (en)	1999-01-06	Novel methods of treatment
EG24158A (en)	2008-08-20	Novel method of treatment
GB9822459D0 (en)	1998-12-09	Method of treatment
GB9808479D0 (en)	1998-06-17	Method of treatment
GB9811961D0 (en)	1998-07-29	Method of treatment